Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 19, 2026.

Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer

Hui Zhou, Liyong Zhu, Jun Song and 9 more

Molecular Cancer · 2022 · Review · CC BY

doi:10.1186/s12943-022-01556-2

Abstract

Supplementary Information. The online version contains supplementary material available at 10.1186/s12943-022-01556-2.

References 258

  1. 1.

    Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-249.

    Not in our library10.3322/caac.21660

  2. 2.

    Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66:683-691.

    Not in our library10.1136/gutjnl-2015-310912

  3. 3.

    Pantel K, Alix-Panabières C. Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol Med. 2010;16:398-406.

    Not in our library10.1016/j.molmed.2010.07.001

  4. 4.

    Lianidou ES, Mavroudis D, Sotiropoulou G, Agelaki S, Pantel K. What's new on circulating tumor cells? A meeting report. Breast Cancer Res. 2010;12:307-307.

    Not in our library10.1186/bcr2601

  5. 5.

    Alix-Panabieres C, Pantel K. Circulating tumor cells: liquid biopsy of Cancer. Clin Chem. 2013;59:110-118.

    Not in our library10.1373/clinchem.2012.194258

  6. 6.

    Ashworth T. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust Med J. 1869;14:146-149.

    Not in our library

  7. 7.

    Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351:781-791.

    Not in our library10.1056/nejmoa040766

  8. 8.

    Röcken M. Early tumor dissemination, but late metastasis: insights into tumor dormancy. J Clin Invest. 2010;120:1800-1803.

    Not in our library10.1172/jci43424

  9. 9.

    Pierga JY, Hajage D, Bachelot T, Delaloge S, Brain E, Campone M, Diéras V, Rolland E, Mignot L, Mathiot C, Bidard FC. High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients. Ann Oncol. 2012;23:618-624.

    Not in our library10.1093/annonc/mdr263

  10. 10.

    Lohr JG, Adalsteinsson VA, Cibulskis K, Choudhury AD, Rosenberg M, Cruz-Gordillo P, Francis JM, Zhang CZ, Shalek AK, Satija R, et al. Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer. Nat Biotechnol. 2014;32:479-484.

    Not in our library10.1038/nbt.2892

  11. 11.

    Jiang R, Lu YT, Ho H, Li B, Chen JF, Lin M, Li F, Wu K, Wu H, Lichterman J, et al. A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer. Oncotarget. 2015;6:44781-44793.

    Not in our library10.18632/oncotarget.6330

  12. 12.

    Mandel P, Metais P. Nuclear acids in human blood plasma. C R Seances Soc Biol Fil. 1948;142:241-243.

    Not in our library

  13. 13.

    Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977;37:646-650.

    Not in our library

  14. 14.

    Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res. 1994;54:3568-3573.

    Not in our library

  15. 15.

    Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res. 1999;59:67-70.

    Not in our library

  16. 16.

    Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, Thornton K, Agrawal N, Sokoll L, Szabo SA, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med. 2008;14:985-990.

    Not in our library10.1038/nm.1789

  17. 17.

    S ELA, Mäger I, Breakefield XO, Wood MJ: extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013;12:347–57.

    Not in our library10.1038/nrd3978

  18. 18.

    Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987;262:9412-9420.

    Not in our library

  19. 19.

    Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, Geuze HJ. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183:1161-1172.

    Not in our library10.1084/jem.183.3.1161

  20. 20.

    Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G, Amigorena S. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med. 1998;4:594-600.

    Not in our library10.1038/nm0598-594

  21. 21.

    Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977.

    Not in our library10.1126/science.aau6977

  22. 22.

    George JN. Platelets. Lancet. 2000;355:1531-1539.

    Not in our library10.1016/s0140-6736(00)02175-9

  23. 23.

    van der Meijden PEJ, Heemskerk JWM. Platelet biology and functions: new concepts and clinical perspectives. Nat Rev Cardiol. 2019;16:166-179.

    Not in our library10.1038/s41569-018-0110-0

  24. 24.

    McAllister SS, Weinberg RA. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol. 2014;16:717-727.

    Not in our library10.1038/ncb3015

  25. 25.

    Trousseau A. Clinique medicale de l'hotel Dieu de Paris quatrieme edition. Medical clinic at Dieu's hotel in Paris. 1873;3.

    Not in our library

  26. 26.

    Wright JH. The origin and nature of the blood plates. Boston Med Surg J. 1906;154:643-645.

    Not in our library

  27. 27.

    Nilsson RJ, Balaj L, Hulleman E, van Rijn S, Pegtel DM, Walraven M, Widmark A, Gerritsen WR, Verheul HM, Vandertop WP, et al. Blood platelets contain tumor-derived RNA biomarkers. Blood. 2011;118:3680-3683.

    Not in our library10.1182/blood-2011-03-344408

  28. 28.
    RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics · 2015
    No notice
  29. 29.

    Pantel K, Speicher MR. The biology of circulating tumor cells. Oncogene. 2016;35:1216-1224.

    Not in our library10.1038/onc.2015.192

  30. 30.

    Tsai WS, You JF, Hung HY, Hsieh PS, Hsieh B, Lenz HJ, Idos G, Friedland S, Yi-Jiun Pan J, Shao HJ, et al. Novel circulating tumor cell assay for detection of colorectal adenomas and Cancer. Clin Transl Gastroenterol. 2019;10:e00088.

    Not in our library10.14309/ctg.0000000000000088

  31. 31.

    Bork U, Rahbari NN, Schölch S, Reissfelder C, Kahlert C, Büchler MW, Weitz J, Koch M. Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study. Br J Cancer. 2015;112:1306-1313.

    Not in our library10.1038/bjc.2015.88

  32. 32.

    Hinz S, Röder C, Tepel J, Hendricks A, Schafmayer C, Becker T, Kalthoff H. Cytokeratin 20 positive circulating tumor cells are a marker for response after neoadjuvant chemoradiation but not for prognosis in patients with rectal cancer. BMC Cancer. 2015;15:953.

    Not in our library10.1186/s12885-015-1989-z

  33. 33.

    Pan RJ, Hong HJ, Sun J, Yu CR, Liu HS, Li PY, Zheng MH. Detection and clinical value of circulating tumor cells as an assisted prognostic marker in colorectal Cancer patients. Cancer Manag Res. 2021;13:4567-4578.

    Not in our library10.2147/cmar.s300554

  34. 34.
    Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer. · 2021
    Not checked
  35. 35.

    Tan Y, Wu H. The significant prognostic value of circulating tumor cells in colorectal cancer: a systematic review and meta-analysis. Curr Probl Cancer. 2018;42:95-106.

    Not in our library10.1016/j.currproblcancer.2017.11.002

  36. 36.

    Groot Koerkamp B, Rahbari NN, Büchler MW, Koch M, Weitz J. Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: a meta-analysis. Ann Surg Oncol. 2013;20:2156-2165.

    Not in our library10.1245/s10434-013-2907-8

  37. 37.

    Connor AA, McNamara K, Al-Sukhni E, Diskin J, Chan D, Ash C, Lowes LE, Allan AL, Zogopoulos G, Moulton CA, Gallinger S. Central, but not peripheral, circulating tumor cells are prognostic in patients undergoing resection of colorectal Cancer liver metastases. Ann Surg Oncol. 2016;23:2168-2175.

    Not in our library10.1245/s10434-015-5038-6

  38. 38.

    Zhao JX, Liu LR, Yang XY, Liu F, Zhang ZG. Serum CA19-9 as a marker of circulating tumor cells in first reflux blood of colorectal cancer patients. Oncotarget. 2017;8:67918-67932.

    Not in our library10.18632/oncotarget.18912

  39. 39.

    Wu F, Zhu J, Mao Y, Li X, Hu B, Zhang D. Associations between the epithelial-mesenchymal transition phenotypes of circulating tumor cells and the Clinicopathological features of patients with colorectal Cancer. Dis Markers. 2017;2017:9474532.

    Not in our library10.1155/2017/9474532

  40. 40.

    Zhong Y, Ma T, Qiao T, Hu H, Li Z, Luo K, Wang Y, Tang Q, Wang G, Huang R, Wang X. Role of phenotypes of circulating tumor cells in the diagnosis and treatment of colorectal Cancer. Cancer Manag Res. 2021;13:7077-7085.

    Not in our library10.2147/cmar.s316544

All 258 references

Cited by papers we hold 6

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.